Patents by Inventor Michael J. Story

Michael J. Story has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5532002
    Abstract: Hard gelatin capsules contain: (a) a fat-soluble nutrient, such as a fat-soluble vitamin (A, D, E or K) or an unsaturated fatty acid glyceride; (b) a nonionic surfactant, such as a polyoxyethylated (optionally hydrogenated) castor oil, and/or a polyethylene glycol; (c) a gelatin softening agent such as glycerol, propylene glycol or, preferably, glyceryl mono-oleate; and optionally (d) water. The problems of embrittlement conventionally encountered with hard gelatin capsules containing fat-soluble nutrients are reduced or avoided.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: July 2, 1996
    Assignee: Cortecs Limited
    Inventor: Michael J. Story
  • Patent number: 5138317
    Abstract: An n-bit DAC of the kind having at least 2.sup.n -1 sources, typically current sources, especially for use in oversampling ADC's enables a resolution accuracy in excess of 18 bits by selecting the sources in a dynamic manner. A source selection circuit typically an at least 2.sup.n -1 to 2.sup.n -1 multiplexer, connected between the digital input lines and the DAC switches selects the sources based on a predetermined cyclic algorithm which converts DAC errors into noise and shifts the noise energy into unwanted parts of the spectrum.
    Type: Grant
    Filed: October 9, 1990
    Date of Patent: August 11, 1992
    Assignee: Data Conversion Systems Limited
    Inventor: Michael J. Story
  • Patent number: 4944949
    Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) including diclofenac, flufenamic acid, flurbiprofen, ibuprofen, indomethacin, ketoprofen, naproxen, phenylbutazone, piroxicam and sulindac are administered in micelles to alleviate their adverse effects on the gastrointestinal tract. The drugs are formulated with surfactants such as polyethoxylated nonionics to give micelle-forming compositions.
    Type: Grant
    Filed: December 17, 1987
    Date of Patent: July 31, 1990
    Assignee: T.I.L. Medical Ltd.
    Inventors: Michael J. Story, Michael J. Flynn